Patents by Inventor Channing Rodney BEALS

Channing Rodney BEALS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS OF A MAGL INHIBITOR
    Publication number: 20220235037
    Abstract: Described herein is the MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, including crystalline forms and pharmaceutically acceptable salts and solvates thereof.
    Type: Application
    Filed: September 8, 2021
    Publication date: July 28, 2022
    Inventors: Cheryl A. GRICE, Todd K. JONES, Kurt G. GRIMM, Jacqueline Lorayne BLANKMAN, Channing Rodney BEALS
  • METHODS OF TREATING DISEASE WITH MAGL INHIBITORS
    Publication number: 20220110933
    Abstract: Provided herein are methods for the treatment of disease with monoacylglycerol lipase (MAGL) inhibitors.
    Type: Application
    Filed: January 24, 2020
    Publication date: April 14, 2022
    Inventor: Channing Rodney BEALS
  • METHODS OF TREATING DISEASE WITH MAGL INHIBITORS
    Publication number: 20220031676
    Abstract: Provided herein are methods for the treatment of disease with monoacylglycerol lipase (MAGL) inhibitors.
    Type: Application
    Filed: November 26, 2019
    Publication date: February 3, 2022
    Inventors: Channing Rodney BEALS, Dallas JONES, Jason Robert CLAPPER, Gary Paul O'NEILL, Iain Peter FRASER, Jacqueline Lorayne BLANKMAN, John J.M. WIENER, Cheryl A. GRICE
  • Crystalline forms of a MAGL inhibitor
    Patent number: 11142517
    Abstract: Described herein is the MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, including crystalline forms and pharmaceutically acceptable salts and solvates thereof.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: October 12, 2021
    Assignee: H. LUNDBECK A/S
    Inventors: Cheryl A. Grice, Todd K. Jones, Kurt G. Grimm, Jacqueline Lorayne Blankman, Channing Rodney Beals
  • METHODS OF TREATING INFLAMMATION OR NEUROPATHIC PAIN
    Publication number: 20210230145
    Abstract: Provided herein are methods of treating inflammation or neuropathic pain using an effective dose of a monoacylglycerol lipase inhibitor or a composition thereof.
    Type: Application
    Filed: April 9, 2021
    Publication date: July 29, 2021
    Inventors: Jacqueline Lorayne BLANKMAN, Jason Robert CLAPPER, R. Alan B. EZEKOWITZ, Iain Peter FRASER, Cheryl A. GRICE, Todd K. JONES, Gary Paul O'NEILL, Archie Wayne THURSTON, JR., Channing Rodney BEALS
  • Methods of treating inflammation or neuropathic pain
    Patent number: 11034674
    Abstract: Provided herein are methods of treating inflammation or neuropathic pain using an effective dose of a monoacylglycerol lipase inhibitor or a composition thereof.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: June 15, 2021
    Assignee: H. LUNDBECK A/S
    Inventors: Jacqueline Lorayne Blankman, Jason Robert Clapper, R. Alan B. Ezekowitz, Iain Peter Fraser, Cheryl A. Grice, Todd K. Jones, Gary Paul O'Neill, Archie Wayne Thurston, Jr., Channing Rodney Beals
  • CRYSTALLINE FORMS OF A MAGL INHIBITOR
    Publication number: 20200190063
    Abstract: Described herein is the MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, including crystalline forms and pharmaceutically acceptable salts and solvates thereof.
    Type: Application
    Filed: November 15, 2017
    Publication date: June 18, 2020
    Inventors: Cheryl A. GRICE, Todd K. JONES, Kurt G. GRIMM, Jaqueline Lorayne BLANKMAN, Channing Rodney BEALS
  • METHODS OF TREATING INFLAMMATION OR NEUROPATHIC PAIN
    Publication number: 20200055841
    Abstract: Provided herein are methods of treating inflammation or neuropathic pain using an effective dose of a monoacylglycerol lipase inhibitor or a composition thereof.
    Type: Application
    Filed: September 6, 2019
    Publication date: February 20, 2020
    Inventors: Jacqueline Lorayne BLANKMAN, Jason Robert CLAPPER, R. Alan B. EZEKOWITZ, Iain Peter FRASER, Cheryl A. GRICE, Todd K. JONES, Gary Paul O'NEILL, Archie Wayne THURSTON, JR., Channing Rodney BEALS
  • Methods of treating inflammation or neuropathic pain
    Patent number: 10450302
    Abstract: Provided herein are methods of treating inflammation or neuropathic pain using an effective dose of a monoacylglycerol lipase inhibitor or a composition thereof.
    Type: Grant
    Filed: May 10, 2016
    Date of Patent: October 22, 2019
    Assignee: LUNDBECK LA JOLLA RESEARCH CENTER, INC.
    Inventors: Jacqueline Lorayne Blankman, Jason Robert Clapper, R. Alan B. Ezekowitz, Iain Peter Fraser, Cheryl A. Grice, Todd K. Jones, Gary Paul O'Neill, Archie Wayne Thurston, Jr., Channing Rodney Beals
  • METHODS OF TREATING INFLAMMATION OR NEUROPATHIC PAIN
    Publication number: 20180099951
    Abstract: Provided herein are methods of treating inflammation or neuropathic pain using an effective dose of a monoacylglycerol lipase inhibitor or a composition thereof.
    Type: Application
    Filed: May 10, 2016
    Publication date: April 12, 2018
    Inventors: Jacqueline Lorayne BLANKMAN, Jason Robert CLAPPER, R. Alan B. EZEKOWITZ, Iain Peter FRASER, Cheryl A. GRICE, Todd K. JONES, Gary Paul O'NEILL, Archie Wayne THURSTON, Jr., Channing Rodney BEALS
  • PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING DRY EYE DISORDERS
    Publication number: 20130303557
    Abstract: Ophthalmic compositions comprising Inhibitors of Janus kinase-3 (“Jak3”) are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
    Type: Application
    Filed: July 17, 2013
    Publication date: November 14, 2013
    Inventors: Channing Rodney BEALS, Elizabeth WOLDEMUSSIE, Hovhannes John GUKASYAN, Jingwen MA